AMA resolution calls for sharing of drug trial info

Share this article:
The American Medical Association (AMA) voted unanimously to
adopt a resolution calling for new guidelines for sharing information
about drug trial results.
The goal of the resolution is to put an end to contract confidentiality
restrictions that often keep researchers who have worked on a
drug trial from discussing the results with other researchers and doctors.
The AMA hopes to enter into talks with the drug industry's trade
organization, the Pharmaceutical Research and Manufacturers of
America, and other groups, to develop those guidelines.
Patient care is endangered when physician researchers are prevented from presenting information from industry-funded studies, the AMA said.
Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?